AM
Insider
Aziz Mottiwala
Chief Commercial OfficerAziz Mottiwala (Chief Commercial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Tarsus Pharmaceuticals, Inc. (TARS). The largest single filing was $893K of TARS (13,056 sh across 3 lots, as filed), executed Mar 17.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$893K
shares × price, as filed
Last traded
Mar 19
Filed Mar 19
Median ADV $68.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
TARSRecent filings
TARSSALE
Tarsus Pharmaceuticals, Inc.
View filing →
$893K13,056 sh across 3 lots
Exec Mar 17
Filed Mar 19 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $766K
17,500 sh × $43.76
Exec Jun 9 2025
Filed Jun 11 2025 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $506K
10,565 sh across 3 lots
Exec Mar 18 2025
Filed Mar 20 2025 · 5:30 PM ET